NeuroPace (NPCE) Cash from Investing Activities (2020 - 2026)
NeuroPace's quarterly Cash from Investing Activities came in at -$117000.0 in Q1 2026, down 216.22% year-on-year from $100674.4 in Q1 2025, and down 20.62% quarter-over-quarter from -$97000.0 in Q4 2025.
NeuroPace has reported Cash from Investing Activities for 7 years, with the latest figure at -$117000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 216.22% year-over-year to -$117000.0; the trailing twelve-month figure through Mar 2026 stood at -$412000.0 (down 106.28% YoY), and the FY2025 full-year result was -$332000.0, down 103.69% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$117000.0, down from -$97000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $10.1 million in Q1 2023, with the low at -$306000.0 in Q1 2022.
- Average Cash from Investing Activities over 5 years is $3.3 million, with a median of $2.4 million recorded in 2024.
- Year-over-year, Cash from Investing Activities jumped 5877.92% in 2022 and plunged 216.22% in 2026.
- Tracing NPCE's Cash from Investing Activities over 5 years: stood at $8.9 million in 2022, then plunged by 61.02% to $3.5 million in 2023, then plunged by 43.45% to $2.0 million in 2024, then sank by 104.95% to -$97000.0 in 2025, then decreased by 20.62% to -$117000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$117000.0 (Q1 2026), -$97000.0 (Q4 2025), and -$30000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | -117,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -117,000.00 |
| Mar 31, 2026 | -117,000.00 |
| Dec 31, 2025 | -97,000.00 |
| Dec 31, 2025 | -97,000.00 |
| Sep 30, 2025 | -30,000.00 |
| Sep 30, 2025 | -30,000.00 |
| Jun 30, 2025 | -168,000.00 |
| Jun 30, 2025 | -168,000.00 |
| Mar 31, 2025 | -37,000.00 |
| Mar 31, 2025 | -37,000.00 |
| Dec 31, 2024 | 1.96 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 3.24 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Dec 31, 2023 | 3.47 Mn |
| Dec 31, 2023 | 3.47 Mn |
| Sep 30, 2023 | 4.19 Mn |
| Sep 30, 2023 | 4.19 Mn |
| Jun 30, 2023 | 5.30 Mn |
| Jun 30, 2023 | 5.30 Mn |
| Mar 31, 2023 | 10.07 Mn |
| Mar 31, 2023 | 10.07 Mn |
| Dec 31, 2022 | 8.90 Mn |
| Dec 31, 2022 | 8.90 Mn |
| Sep 30, 2022 | 6.97 Mn |
| Sep 30, 2022 | 6.97 Mn |
| Jun 30, 2022 | 8.24 Mn |
| Jun 30, 2022 | 8.24 Mn |
| Mar 31, 2022 | -306,000.00 |
| Mar 31, 2022 | -306,000.00 |
| Dec 31, 2021 | -154,000.00 |
| Dec 31, 2021 | -154,000.00 |
| Sep 30, 2021 | -190,000.00 |
| Sep 30, 2021 | -190,000.00 |
| Jun 30, 2021 | -80.02 Mn |
| Jun 30, 2021 | -80.02 Mn |
| Mar 31, 2021 | -5.04 Mn |
| Mar 31, 2021 | -5.04 Mn |
| Dec 31, 2020 | -10.05 Mn |
| Dec 31, 2020 | -10.05 Mn |
| Sep 30, 2020 | -250,000.00 |
| Sep 30, 2020 | -250,000.00 |
| Mar 31, 2020 | -471,000.00 |
| Mar 31, 2020 | -471,000.00 |